Hollsteen
← Ciena

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: $627M · 10-Q 0000936395-16-000083 filed Mar 9, 2016Equity incl. NCI · Q2 FY2016: $669M · 10-Q 0000936395-16-000104 filed Jun 8, 2016Equity incl. NCI · Q3 FY2016: $722M · 10-Q 0000936395-16-000115 filed Sep 7, 2016Equity incl. NCI · Q4 FY2016: $766M · 10-K 0000936395-16-000128 filed Dec 21, 2016Equity incl. NCI · Q1 FY2017: $799M · 10-Q 0000936395-17-000020 filed Mar 8, 2017Equity incl. NCI · Q2 FY2017: $847M · 10-Q 0000936395-18-000024 filed Jun 6, 2018Equity incl. NCI · Q3 FY2017: $944M · 10-Q 0000936395-17-000051 filed Sep 7, 2017Equity incl. NCI · Q4 FY2017: $2.1B · 10-K 0000936395-17-000064 filed Dec 22, 2017Equity incl. NCI · Q1 FY2018: $1.8B · 10-Q 0000936395-18-000013 filed Mar 7, 2018Equity incl. NCI · Q2 FY2018: $1.7B · 10-Q 0000936395-18-000024 filed Jun 6, 2018Equity incl. NCI · Q3 FY2018: $1.8B · 10-Q 0000936395-18-000037 filed Sep 5, 2018Equity incl. NCI · Q4 FY2018: $1.9B · 10-K 0000936395-18-000048 filed Dec 21, 2018Equity incl. NCI · Q1 FY2019: $2.1B · 10-Q 0000936395-19-000010 filed Mar 11, 2019Equity incl. NCI · Q2 FY2019: $2.1B · 10-Q 0000936395-19-000021 filed Jun 12, 2019Equity incl. NCI · Q3 FY2019: $2.1B · 10-Q 0000936395-19-000040 filed Sep 11, 2019Equity incl. NCI · Q4 FY2019: $2.2B · 10-K 0000936395-19-000056 filed Dec 20, 2019Equity incl. NCI · Q1 FY2020: $2.2B · 10-Q 0000936395-20-000011 filed Mar 11, 2020Equity incl. NCI · Q2 FY2020: $2.2B · 10-Q 0000936395-20-000028 filed Jun 10, 2020Equity incl. NCI · Q3 FY2020: $2.4B · 10-Q 0000936395-20-000036 filed Sep 9, 2020Equity incl. NCI · Q4 FY2020: $2.5B · 10-K 0000936395-20-000042 filed Dec 18, 2020Equity incl. NCI · Q1 FY2021: $2.6B · 10-Q 0000936395-21-000010 filed Mar 10, 2021Equity incl. NCI · Q2 FY2021: $2.7B · 10-Q 0000936395-21-000034 filed Jun 9, 2021Equity incl. NCI · Q3 FY2021: $2.9B · 10-Q 0000936395-21-000040 filed Sep 8, 2021Equity incl. NCI · Q4 FY2021: $3.0B · 10-K 0000936395-21-000054 filed Dec 17, 2021Equity incl. NCI · Q1 FY2022: $2.8B · 10-Q 0000936395-22-000029 filed Mar 9, 2022Equity incl. NCI · Q2 FY2022: $2.8B · 10-Q 0000936395-22-000045 filed Jun 8, 2022Equity incl. NCI · Q3 FY2022: $2.7B · 10-Q 0000936395-22-000053 filed Sep 7, 2022Equity incl. NCI · Q4 FY2022: $2.7B · 10-K 0000936395-22-000065 filed Dec 16, 2022Equity incl. NCI · Q1 FY2023: $2.8B · 10-Q 0000936395-23-000014 filed Mar 8, 2023Equity incl. NCI · Q2 FY2023: $2.9B · 10-Q 0000936395-23-000027 filed Jun 7, 2023Equity incl. NCI · Q3 FY2023: $2.9B · 10-Q 0000936395-23-000034 filed Sep 6, 2023Equity incl. NCI · Q4 FY2023: $2.8B · 10-K 0000936395-23-000044 filed Dec 15, 2023Equity incl. NCI · Q1 FY2024: $2.9B · 10-Q 0000936395-24-000008 filed Mar 7, 2024Equity incl. NCI · Q2 FY2024: $2.9B · 10-Q 0000936395-24-000025 filed Jun 6, 2024Equity incl. NCI · Q3 FY2024: $2.9B · 10-Q 0000936395-24-000032 filed Sep 4, 2024Equity incl. NCI · Q4 FY2024: $2.8B · 10-K 0000936395-24-000044 filed Dec 20, 2024Equity incl. NCI · Q1 FY2025: $2.8B · 10-Q 0000936395-25-000011 filed Mar 12, 2025Equity incl. NCI · Q2 FY2025: $2.8B · 10-Q 0000936395-25-000025 filed Jun 5, 2025Equity incl. NCI · Q3 FY2025: $2.8B · 10-Q 0000936395-25-000041 filed Sep 4, 2025Equity incl. NCI · Q4 FY2025: $2.7B · 10-K 0001628280-25-056698 filed Dec 12, 2025Equity incl. NCI · Q1 FY2026: $2.8B · 10-Q 0001628280-26-015152 filed Mar 5, 2026Equity incl. NCI · Q2 FY2026: $2.9B · 10-Q 0001628280-26-040767 filed Jun 4, 2026Equity incl. NCI · Q3 FY2026: $3.1B · 10-Q 0001628280-26-060361 filed Sep 3, 20262,8153,057627Q1 FY2016Q3 FY2026Q1 FY2022
$MEquity incl. NCI · Q1 FY2021: $2.6B · 10-Q 0000936395-21-000010 filed Mar 10, 2021Equity incl. NCI · Q2 FY2021: $2.7B · 10-Q 0000936395-21-000034 filed Jun 9, 2021Equity incl. NCI · Q3 FY2021: $2.9B · 10-Q 0000936395-21-000040 filed Sep 8, 2021Equity incl. NCI · Q4 FY2021: $3.0B · 10-K 0000936395-21-000054 filed Dec 17, 2021Equity incl. NCI · Q1 FY2022: $2.8B · 10-Q 0000936395-22-000029 filed Mar 9, 2022Equity incl. NCI · Q2 FY2022: $2.8B · 10-Q 0000936395-22-000045 filed Jun 8, 2022Equity incl. NCI · Q3 FY2022: $2.7B · 10-Q 0000936395-22-000053 filed Sep 7, 2022Equity incl. NCI · Q4 FY2022: $2.7B · 10-K 0000936395-22-000065 filed Dec 16, 20222,8152,7132,587Q1 FY2021Q4 FY2022Q1 FY2022
Q1 FY2022
2,815$M
All values (43)
PeriodValue ($M)Status
Q3 FY20263,057reported
Q2 FY20262,892reported
Q1 FY20262,792reported
Q4 FY20252,729reported
Q3 FY20252,787reported
Q2 FY20252,776reported
Q1 FY20252,793reported
Q4 FY20242,816reported
Q3 FY20242,891reported
Q2 FY20242,880reported
Q1 FY20242,923reported
Q4 FY20232,848reported
Q3 FY20232,947reported
Q2 FY20232,909reported
Q1 FY20232,838reported
Q4 FY20222,713reported
Q3 FY20222,668reported
Q2 FY20222,782reported
Q1 FY20222,815reported
Q4 FY20213,020reported
Q3 FY20212,924reported
Q2 FY20212,693reported
Q1 FY20212,587reported
Q4 FY20202,510reported
Q3 FY20202,429reported
Q2 FY20202,241reported
Q1 FY20202,194reported
Q4 FY20192,173reported
Q3 FY20192,119reported
Q2 FY20192,063reported
Q1 FY20192,054reported
Q4 FY20181,929reported
Q3 FY20181,779reported
Q2 FY20181,744reported
Q1 FY20181,756reported
Q4 FY20172,136reported
Q3 FY2017944reported
Q2 FY2017847reported
Q1 FY2017799reported
Q4 FY2016766reported
Q3 FY2016722reported
Q2 FY2016669reported
Q1 FY2016627reported

CSV with all sources · Technical ID: equity_total

More metrics for Ciena

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Gross profit by segment

Sources & calculation
Value
$2.8B
Period
Q1 FY2022, ended Jan 29, 2022 · as of Jan 29, 2022 (balance as of date, not a sum)
Source
10-Q, filed Mar 9, 2022 · 0000936395-22-000029
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$2.8BMar 9, 202210-Q 0000936395-22-000029reported · confidence 1. · current